Cerenome, Inc.
CNSY- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001095981
No open-market purchases or sales by Cerenome, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.89M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Cerenome, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −4 vs. Q2 2021
- Shares held
- 1.30M
- −308.5K (−19.2%) vs. Q2 2021
- Total value
- $2.48M
- −$1.64M (−39.7%) vs. Q2 2021
- New holders
- 0
- 4 more added
- Sold out
- 4
- 6 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $2.89M |
| Q1 2026 | 25 | $1.49M |
| Q4 2025 | 27 | $5.92M |
| Q3 2025 | 23 | $3.57M |
| Q2 2025 | 19 | $131.6K |
| Q1 2025 | 17 | $368.7K |
| Q4 2024 | 11 | $779.9K |
| Q3 2024 | 11 | $980.5K |
| Q2 2024 | 12 | $1.00M |
| Q1 2024 | 10 | $181.8K |
| Q4 2023 | 12 | $247.4K |
| Q3 2023 | 12 | $117.9K |
| Q2 2023 | 7 | $205.5K |
| Q1 2023 | 25 | $588.3K |
| Q4 2022 | 30 | $872.1K |
| Q3 2022 | 28 | $1.58M |
| Q2 2022 | 26 | $1.93M |
| Q1 2022 | 23 | $3.26M |
| Q4 2021 | 24 | $2.03M |
| Q3 2021 | 18 | $2.48M |
| Q2 2021 | 22 | $4.11M |
| Q1 2021 | 18 | $717.0K |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Cerenome, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 712,847 | $1.36M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 258,437 | $493.0K | 0.00% | +127,644+97.6% | Added |
| BlackRock Inc. | 128,323 | $245.0K | 0.00% | −31,537−19.7% | Reduced |
| Two Sigma Advisers, LP | 61,400 | $117.0K | 0.00% | −114,100−65.0% | Reduced |
| State Street Corp | 34,414 | $66.0K | 0.00% | +200+0.6% | Added |
| Northern Trust Corp | 32,089 | $61.0K | 0.00% | −8,435−20.8% | Reduced |
| Dimensional Fund Advisors LP | 25,507 | $49.0K | 0.00% | −42,923−62.7% | Reduced |
| Creative Planning | 18,539 | $35.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 16,387 | $31.0K | 0.00% | −92,137−84.9% | Reduced |
| Advisor Group Holdings, Inc. | 9,005 | $17.0K | 0.00% | +1,000+12.5% | Added |
| Bank of America Corp | 2,225 | $4.00K | 0.00% | +2,215+22,150.0% | Added |
| Financial Perspectives, Inc | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 75 | $0 | 0.00% | −62−45.3% | Reduced |
| Harbour Investments, Inc. | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 38 | $0 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 21 | $0 | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −76,187−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −43,529−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −17,607−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −13,033−100.0% | Sold out |